| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adjuvant chemotherapy in patients with rectal cancer achieving pathologic complete response after neoadjuvant chemoradiation and surgery
|
Tomasello, Gianluca
|
|
2019
|
108 |
C |
p. 97-99
|
article
|
| 2 |
A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer
|
Bang, Y.-J.
|
|
2019
|
108 |
C |
p. 17-24
|
article
|
| 3 |
Circulating innate immune markers and outcomes in treatment-naïve advanced non–small cell lung cancer patients
|
Charrier, M.
|
|
2019
|
108 |
C |
p. 88-96
|
article
|
| 4 |
Immunotherapy comes of age in octagenarian and nonagenarian metastatic melanoma patients
|
Ben-Betzalel, Guy
|
|
2019
|
108 |
C |
p. 61-68
|
article
|
| 5 |
NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors
|
Wang-Gillam, Andrea
|
|
2019
|
108 |
C |
p. 78-87
|
article
|
| 6 |
Neoepitopes-based vaccines: challenges and perspectives
|
Alcazer, Vincent
|
|
2019
|
108 |
C |
p. 55-60
|
article
|
| 7 |
Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial
|
Livi, Lorenzo
|
|
2019
|
108 |
C |
p. 100-110
|
article
|
| 8 |
Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study
|
Gérard, Jean-Pierre
|
|
2019
|
108 |
C |
p. 1-16
|
article
|
| 9 |
Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer
|
Levy, Benjamin P.
|
|
2019
|
108 |
C |
p. 120-128
|
article
|
| 10 |
Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma
|
Auvray, Marie
|
|
2019
|
108 |
C |
p. 33-40
|
article
|
| 11 |
State of clinical research of radiotherapy/chemoradiotherapy and immune checkpoint inhibitor therapy combinations in solid tumours—a German radiation oncology survey
|
Käsmann, Lukas
|
|
2019
|
108 |
C |
p. 50-54
|
article
|
| 12 |
Stromal lymphocyte infiltration is associated with tumour invasion depth but is not prognostic in high-grade T1 bladder cancer
|
Rouanne, Mathieu
|
|
2019
|
108 |
C |
p. 111-119
|
article
|
| 13 |
TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinoma
|
Bournaud, Claire
|
|
2019
|
108 |
C |
p. 41-49
|
article
|
| 14 |
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial
|
Bjarnason, Georg A.
|
|
2019
|
108 |
C |
p. 69-77
|
article
|
| 15 |
The real-world impact of modern treatments on the survival of patients with metastatic melanoma
|
Donia, Marco
|
|
2019
|
108 |
C |
p. 25-32
|
article
|
Journal description